References
- Allen, S. T., O’Rourke, A., White, R. H., Schneider, K. E., Kilkenny, M., & Sherman, S. G. (2019). Estimating the number of people who inject drugs in a rural county in Appalachia. American Journal of Public Health. Article 1–6. https://doi.org/10.2105/AJPH.2018.304873
- Allen, S. T., White, R. H., O’Rourke, A., Grieb, S. M., Kilkenny, M. E., & Sherman, S. G. (2019). Take-home naloxone possession among people who inject drugs in rural West Virginia. Drug and Alcohol Dependence, 204, Article 107581. https://doi.org/10.1016/j.drugalcdep.2019.107581
- Alpren, C., Dawson, E. L., John, B., Cranston, K., Panneer, N., Fukuda, H. D., Roosevelt, K., Klevens, R. M., Bryant, J., Peters, P. J., Lyss, S. B., Switzer, W. M., Burrage, A., Murray, A., Agnew-Brune, C., Stiles, T., McClung, P., Campbell, E. M., Breen, C., … Buchacz, K. (2020). Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs—Massachusetts, 2015–2018. American Journal of Public Health, 110(1), 37–44. https://doi.org/10.2105/AJPH.2019.305366
- Atkins, A., McClung, R. P., Kilkenny, M., Bernstein, K., Willenburg, K., Edwards, A., Lyss, S., Thomasson, E., Panneer, N., Kirk, N., Watson, M., Adkins, E., DiNenno, E., Hogan, V., Neblett Fanfair, R., Napier, K., Ridpath, A. D., Perdue, M., Chen, M., … Oster, A. M. (2020). Notes from the field: Outbreak of human immunodeficiency virus infection among persons who inject drugs—Cabell County, West Virginia, 2018–2019. MMWR. Morbidity and Mortality Weekly Report, 69(16), 499–500. https://doi.org/10.15585/mmwr.mm6916a2
- Biello, K., Edeza, A., Salhaney, P., Biancarelli, D., Mimiaga, M., Drainoni, M., Childs E. S., & Bazzi, A. (2019). A missing perspective: Injectable pre-exposure prophylaxis for people who inject drugs. AIDS Care, 31(10), 1214–1220. https://doi.org/10.1080/09540121.2019.1587356
- Centers for Disease Control and Prevention. (2018). US public health service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: Clinical providers’ supplement. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-provider-supplement-2017.pdf
- Cloud, D. H., Ibragimov, U., Prood, N., Young, A. M., & Cooper, H. L. (2019). Rural risk environments for hepatitis c among young adults in Appalachian Kentucky. International Journal of Drug Policy, 72, 47–54. https://doi.org/10.1016/j.drugpo.2019.05.006
- Conrad, C., Bradley, H. M., Broz, D., Buddha, S., Chapman, E. L., Galang, R. R., … Patel, M. R. (2015). Community outbreak of HIV infection linked to injection drug use of oxymorphone—Indiana, 2015. MMWR. Morbidity and Mortality Weekly Report, 64(16), 443.
- Cranston, K., Alpren, C., John, B., Dawson, E., Roosevelt, K., Burrage, A., Bryant, J., Switzer, W. M., Breen, C., Peters, P. J., Stiles, T., Murray, A., Fukuda, H. D., Adih, W., Goldman, L., Panneer, N., Callis, B., Campbell, E. M., Randall, L., … DeMaria, A. (2019). Notes from the field: HIV diagnoses among persons who inject drugs—Northeastern Massachusetts, 2015–2018. MMWR. Morbidity and Mortality Weekly Report, 68(10), 253–254. https://doi.org/10.15585/mmwr.mm6810a6
- Des Jarlais, D. C., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., & Holtzman, D. (2015). Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. MMWR. Morbidity and Mortality Weekly Report, 64(48), 1337–1341. https://doi.org/10.15585/mmwr.mm6448a3
- Eisingerich, A. B., Wheelock, A., Gomez, G. B., Garnett, G. P., Dybul, M. R., & Piot, P. K. (2012). Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PloS One, 7(1), Article 28238. https://doi.org/10.1371/journal.pone.0028238
- Escudero, D. J., Kerr, T., Wood, E., Nguyen, P., Lurie, M. N., Sued, O., & Marshall, B. D. (2015). Acceptability of HIV pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in a Canadian setting. AIDS and Behavior, 19(5), 752–757. https://doi.org/10.1007/s10461-014-0867-z
- Evans, M. E., Labuda, S. M., Hogan, V., Agnew-Brune, C., Armstrong, J., Karuppiah, A. B. P., Blankinship, D., Buchacz, K., Burton, K., Cibrik, S., Hoffman, W., Kirk, N., Lee, C., McGraw, D., Bañez Ocfemia, M. C., Panneer, N., Reynolds, P., Rose, B., Salmon, M., … Mark-Carew, M. (2018). Notes from the field: HIV infection investigation in a rural area—West Virginia, 2017. MMWR. Morbidity and Mortality Weekly Report, 67(8), 257–258. https://doi.org/10.15585/mmwr.mm6708a6
- Food and Drug Administration. (2014). Truvada for PrEP fact sheet: Ensuring safe and proper use. www.fda.gov/downloads/NewsEvents/Newsroom/FactSheets/UCM312279.pdf
- Gonsalves, G. S., & Crawford, F. W. (2018). Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: A modelling study. The Lancet HIV, 5(10), Article 569–577. https://doi.org/10.1016/S2352-3018(18)30176-0
- Guise, A., Albers, E. R., & Strathdee, S. A. (2017). ‘PrEP is not ready for our community, and our community is not ready for PrEP’: Pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response. Addiction, 112(4), 572–578. https://doi.org/10.1111/add.13437
- Hamilton County Public Health. (2018). Hamilton county & Northern Kentucky health work with CDC to investigate HIV cluster. Retrieved 2020, from https://www.hamiltoncountyhealth.org/announcements/hiv_nky/
- Harris, M., & Rhodes, T. (2013). Hepatitis C treatment access and uptake for people who inject drugs: A review mapping the role of social factors. Harm Reduction Journal, 10(1), 7. https://doi.org/10.1186/1477-7517-10-7
- Kuo, I., Olsen, H., Patrick, R., Phillips, G., Magnus, M., Opoku, J., Rawls, A., Peterson, J., Hamilton, F., Kharfen, M., & Greenberg, A. (2016). Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug and Alcohol Dependence, 164, 8–13. https://doi.org/10.1016/j.drugalcdep.2016.02.044
- Lang, K., Neil, J., Wright, J., Dell, C. A., Berenbaum, S., & El-Aneed, A. (2013). Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: Perspectives of service providers. Substance Abuse Treatment, Prevention, and Policy, 8(1), 1–11. https://doi.org/10.1186/1747-597X-8-35
- Lo, A., Kerr, T., Hayashi, K., Milloy, M.-J., Nosova, E., Liu, Y., & Fairbairn, N. (2018). Factors associated with methadone maintenance therapy discontinuation among people who inject drugs. Journal of Substance Abuse Treatment, 94, 41–46. https://doi.org/10.1016/j.jsat.2018.08.009
- Northern Kentucky Health Department. (2018). As HIV cluster investigation moves into second month, health officials increase opportunities for HIV testing. Retrieved 2020, from https://nkyhealth.org/2018/02/22/as-hiv-cluster-investigation-moves-into-second-month-health-officials-increase-opportunities-for-hiv-testing/
- Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. International Journal of Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004
- Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., Conrad, C., Gentry, J., Khudyakov, Y., Waterhouse, D., Owen, S. M., Chapman, E., Roseberry, J. C., McCants, V., Weidle, P. J., … Duwve, J. M. (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. New England Journal of Medicine, 375(3), 229–239. https://doi.org/10.1056/NEJMoa1515195
- Schneider, K. E., O’Rourke, A., White, R. H., Park, J. N., Musci, R. J., Kilkenny, M. E., Sherman, S. G., & Allen, S. T. (2020). Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. International Journal of Drug Policy, 76, Article 102642. https://doi.org/10.1016/j.drugpo.2019.102642
- Sherman, S. G., Schneider, K. E., Park, J. N., Allen, S. T., Hunt, D., Chaulk, C. P., & Weir, B. W. (2019). PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Dependence, 195, 148–155. https://doi.org/10.1016/j.drugalcdep.2018.08.014
- Shrestha, R., Karki, P., Altice, F. L., Huedo-Medina, T. B., Meyer, J. P., Madden, L., & Copenhaver, M. (2017). Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug-and sex-related behaviors among high-risk drug users on methadone treatment. Drug and Alcohol Dependence, 173, 107–116. https://doi.org/10.1016/j.drugalcdep.2016.12.023
- StataCorp, L. (2015). Stata statistical software (Version release 14). StataCorp LP.
- Stein, M., Thurmond, P., & Bailey, G. (2014). Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS and Behavior, 18(9), 1694–1700. https://doi.org/10.1007/s10461-014-0778-z
- Sutton, M., Anthony, M. N., Vila, C., McLellan-Lemal, E., & Weidle, P. J. (2010). HIV testing and HIV/AIDS treatment services in rural counties in 10 southern states: Service provider perspectives. The Journal of Rural Health, 26(3), 240–247. https://doi.org/10.1111/j.1748-0361.2010.00284.x
- US Census Bureau. (2012). 2010 census urban and rural classification and urban area criteria. https://www.census.gov/geo/reference/ua/urban-rural-2010.html
- US Department of Health & Human Services. (2019). Long-acting HIV prevention tools. Retrieved 2020, from https://www.hiv.gov/hiv-basics/hiv-prevention/potential-future-options/long-acting-prep
- US Preventive Services Task Force. (2019). Preexposure prophylaxis for the prevention of HIV infection: US preventive services task force recommendation statement USPSTF guideline. JAMA, 321(22), 2203–2213. doi:10.1001/jama.2019.6390 https://doi.org/10.1001/jama.2019.6390
- Van Handel, M. M., Rose, C. E., Hallisey, E. J., Kolling, J. L., Zibbell, J. E., Lewis, B., & Siddiqi, A.-E. (2016). County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. JAIDS, 73, 323–331. https://doi.org/10.1097/QAI.0000000000001098
- Walters, S. M., Rivera, A. V., Starbuck, L., Reilly, K. H., Boldon, N., Anderson, B. J., & Braunstein, S. (2017). Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for HIV in New York State. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75, S383–S391. https://doi.org/10.1097/QAI.0000000000001415
- White, R. H., O’Rourke, A., Bluthenthal, R. N., Kral, A. H., Kilkenny, M. E., Hazelett, T. D., Sherman, S. G., & Allen, S. T. (2020). Initiating persons into injection drug use in rural West Virginia, USA. Substance Use & Misuse, 55(2), 337–344. doi: 10.1080/10826084.2019.1669660